A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)
Clinical trial NCT05810961 · TERMINATED
Trial details
- NCT number
- NCT05810961
- Sponsor
- argenx
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2024-08-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.